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Abstract
Sindbis virus (SINV) is a mosquito-borne avian hosted virus that is widely distributed in Europe, Africa, Asia,
and Oceania. Disease in humans is documented mainly from Northern Europe and South Africa and associated
with genotype I. In 2018 under extremely warm climatic conditions, a small outbreak of 71 diagnosed SINV
infections was recorded in Finland. We screened 52 mosquito pools (570 mosquitoes) and 223 human sera for
SINV with real-time RT-PCR and the positive samples with virus isolation. One SINV strain was isolated from
a pool (n = 13) of genus Ochlerotatus mosquitoes and three strains from patient serum samples. Complete
genome analysis suggested all the isolates to be divergent from one another and related to previous Finnish,
Swedish, and German strains. The study provides evidence of SINV strain transfer within Europe across regions
with different epidemiological characteristics. Whether these are influenced by different mosquito genera
involved in the transmission remains to be studied.
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Introduction
S indbis virus (SINV) (Genus Alphavirus) is a mosquito-borne virus with a life cycle involving amplifying avian
host (Hubalek 2008). The distribution of the six genotypes of
SINV covers Europe, Africa, Asia, and Oceania. Human
cases are mainly detected from Northern Europe and South
Africa where genotype I is circulating. The recent compre-
hensive phylogenetic analysis suggests that SINV was im-
ported from Africa to Northern Europe, possibly first to
Sweden, by migratory birds (Ling et al. 2019).
In Finland SINV infections are diagnosed annually in late
summer (Brummer-Korvenkontio et al. 2002). The ser-
oprevalence for SINV is highest in Eastern Finland (16%)
and increases with age (Kurkela et al. 2008). The disease
caused by SINV, known as Pogosta disease in Finland,
manifests after a median incubation period of 4 days with
arthralgia, arthritis, myalgia, rash, and fever (Kurkela et al.
2005). The symptoms are usually self-limiting and clear
spontaneously within a few weeks, but in 25% of patients the
symptoms persist at least 3 years and have an impact in the
quality of life (Kurkela et al. 2008).
In Finland the larger SINV outbreaks of hundreds of cases
occur approximately once in a decade. The latest larger epi-
demic was observed in 2012 with 189 cases (‘‘National In-
fectious Disease Registry maintained by the Finnish Institute
for Health and Welfare’’ 2019, Brummer-Korvenkontio et al.
2002). Environmental factors known to promote SINV trans-
mission in Northern Europe include high summer temperature
and precipitation and thick snow layer during the spring (Ja-
lava et al. 2013). Summer 2018 was unusually warm and dry in
all Europe, including Finland. Average summer temperature
between June and August was 2 higher than usual, and pre-
cipitation was half of normal in Finland (FMI 2019).
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In Southern and Eastern Europe, exceptionally high num-
bers of infections caused by another mosquito-borne and bird
hosted virus, West Nile virus, were observed (ECDC 2018). In
Finland a small outbreak of SINV with 71 diagnoses was
observed (National Infectious Disease Registry maintained by
the Finnish Institute for Health and Welfare 2019).
Materials and Methods
To study SINV during this exceptional season, mosquitoes
were collected in known endemic region at three locations in
August 2018 (Fig. 1) using Prokopack (The John W. Hock
Company, Gainesville) and Mosquito Magnet Pioneer
(Woodstream Corporation, Lancaster) trap with Octenol at-
tractant. Collections were done during daytime and evenings
in forests, bogs, and gardens, and the specimens were kept in
empty tubes or in Virocult medium (Medical Wire, England)
on dry ice while being transported to -80C storage. Out of
570 female mosquitoes 52 pools consisting of 1–30 individuals
were constructed based on morphologically identified genus
(Becker et al. 2010), collection site, and blood feeding status.
In Finland, 2018, altogether 71 SINV clinical cases were
documented in late summer/early autumn, which is more than
in a few preceding years (Fig. 2). The patient serum samples
for this study were obtained from Helsinki University Hos-
pital (HUSLAB) where the samples had been sent for sero-
logical testing in 2018 from different health care facilities
throughout Finland (project TYH2018322, Research permit
HUS/32/2018). The serodiagnosis of the patients was based
in IgM and IgG detection using methodology by Manni et al.
(2008). The samples selected for this study included acute
phase serum samples from diagnosed Sindbis patients
(n = 31) for whom also a consecutive sample was available
with IgM and IgG seroconversion. In addition, samples of
192 patients suspected for SINV infection, but without the
serological diagnosis, were included in the study.
For screening mosquitoes were processed in pools. The
mosquito pools were homogenized to Dulbecco’s phosphate-
buffered saline supplemented with 0.2% bovine serum albu-
min using Qiagen TissueLyser. Nucleic acids were extracted
from 140 lL mosquito homogenate and human serum samples
and eluted in 50 lL of elution buffer using QIAamp Viral
FIG. 1. Map of Finland showing the locations of diagnosed SINV infections in 2018 and origin of virus isolation positive
patient sample. The collection sites (indicated with white and red circles) of the mosquito pools are shown in zoomed map
of Mekrijärvi. The virus isolation positive mosquito pool (P1) was collected on 13th of August from a garden (location
indicated with a red circle). SINV, Sindbis virus. Map was created with ESRI ArcGIS (version 10.3.1) by using open source
GIS data (Finnish Environment Institute 2018; NLS of Finland 2000). Hillshade was created in ArcGIS from a digital
elevation model (DEM) with 25-m resolution (NLS of Finland 2000). Color images are available online.
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RNA Mini Kit (Qiagen) or QIAamp 96 Virus QIAcube HT
Kit (Qiagen) according to manufacturer’s instructions.
Samples were studied using SINV real-time RT-PCR ac-
cording to primers, probe, and protocol of Sane et al. (2012a)
with the exception of using TaqMan Fast Virus 1-Step Master
Mix (Thermo Fisher Scientific) reagents. Real-time RT-PCR
was repeated for positive samples, except one human serum
in which we had no volume enough left. BHK-21 (baby
hamster kidney) and Vero E6 (green monkey kidney) cells
grown in 6-well plates were infected with 100 lL of mosquito
homogenate or human serum and observed daily for cyto-
pathic effects for duration of 2 weeks.
For molecular identification purposes mitochondrial cyto-
chrome c oxidase subunit 1 (COI) gene region PCR (Folmer
et al. 1994) was performed for the nucleic acids extracted from
virus positive mosquito pool using DreamTaq DNA polymerase
FIG. 2. Number of SINV diagnoses in 2009–2018 (a) and epidemic curve of SINV 2018 in Finland (b) (National
Infectious Disease Registry maintained by the Finnish Institute for Health and Welfare 2019).
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(Thermo Fisher Scientific), and the product was subjected to
Sanger (University of Helsinki, Institute of Biotechnology,
DNA sequencing and genomics) and Next-Generation sequen-
cing (in-house Illumina MiSeq) sequencing.
SINV genomes were sequenced from the viral isolates
using Illumina MiSeq. RNA was extracted from isolation
culture supernatants with TRIzol Reagent (Thermo Fisher
Scientific), and libraries were prepared using NEBNext Ultra
RNA Library Prep Kit (New England Biolabs) according to
manufacturer’s instructions. Low quality (quality score <30)
sequences were removed using Trimmomatic followed by de
novo assembly using Megahit and reassembly against the de
novo assembled consensus sequences using BWA-MEM al-
gorithm (Li 2013, Bolger et al. 2014, Li et al. 2015).
Phylogenetic tree was constructed using complete coding
sequences of SINV. The sequences that form northern Euro-
pean subgroup of SINV genotype I (Ling et al. 2019) were
downloaded from the GenBank and aligned using ClustalW
algorithm implemented in MEGA7 (Kumar et al. 2016). The
alignment was manually edited to include only the concatenated
open reading frames of SINV genome. The best fit substitution
model was estimated using jModeltest2 (Kumar et al. 2016).
Phylogenetic tree was constructed using Bayesian Monte Carlo
Markov Chain method and GTR + G substitution model im-
plemented in MrBayes (Ronquist and Huelsenbeck 2003). The
posterior probabilities are shown for each node. Viral sequences
obtained in this study are deposited to GenBank with acc. nos.
MN389434 (Ochlerotatus sp) and MN389435, MT270144, and
MT270145 (human serum isolates).
Results
One out of 52 mosquito pools and eight out of 223 human
sera were positive in SINV real-time RT-PCR. Out of the eight
positive human sera, two were samples from patients with se-
rodiagnosis and six were from patients without diagnosis. Six
of these samples were repeatedly positive. With one sample,
the PCR could not be repeated because of lack of the volume of
RNA and one sample was negative when repeated. Virus iso-
lation confirmed the RNA positivity in the mosquito pool
(Sample FIN_2018_M_P1) and in three patient serum samples
(FIN_2018_H_37; 25 and 05). The isolates formed cytopathic
effect (CPE) in 2–4 days in both of the tested cell lines.
The studied mosquito pools represented mostly Ochler-
otatus genus (n = 35), but also Culex (n = 2), Aedes (n = 13),
and Coquillettidia (n = 2) genera were identified and pooled for
screening. The SINV positive mosquito pool consisted of 13
individual female Ochlerotatus mosquitoes collected on 13th
of August 2018 using Prokopack aspirator during evening
from the yard of a rural settlement next to Mekrijärvi (Fig. 1)
and stored in Virocult medium. Nucleotide Basic Local
Alignment Search Tool (BLAST) results of the Sanger se-
quenced COI PCR product of 530 bp (MN422093), and the
sequences obtained from NGS sequencing of the same PCR
product (data not shown) were in line with the morphological
identification of Ochlerotatus genus, but failed to provide re-
liable identification of the exact species comprising the pool.
The sequence from Sanger sequencing showed highest nu-
cleotide identity to Ochlerotatus communis (<95%), whereas
the NGS sequencing results shared highest percentage identi-
ties to Ochlerotatus annulipes from Sweden (96.79%) and
Ochlerotatus excrucians from the United States (96.04%) and
furthermore demonstrated numerous polymorphic sites that
may result from multiple species existing in the pool.
In the phylogenetic analysis of the obtained SINV com-
plete genome data, the virus isolate from mosquito pool
FIN_2018_M_P1 clustered with a virus strain isolated from
mosquitoes from the same area in Ilomantsi, Finland, 2005.
Within the same clade, also one of the human isolates Strain
FIN_2018_H05 was located (Fig. 3). The patient serum iso-
late FIN_2018_H_37 was clustered with strains isolated from
mosquitoes and woodpigeon in Southwest Germany 2009–
2016 ( Jost et al. 2010, Scheuch et al. 2018). The human
serum isolate FIN_2018_H_25 was clustered with previous
Finnish human blood isolate from 2002 Ilomantsi and
Swedish Lovanger strain from Culiseta morsitans, 2013.
These subclusters formed a larger group together with strains
from Finland, Russia, Germany, and Sweden. The SINV
serum isolate FIN_2018_H_37 was obtained from the acute-
phase sample of a SINV diagnosed 75-year-old male who had
no recent travel history and, thus, likely obtained the infec-
tion in his residence commune of Laukaa, Central Finland
(Fig. 1). The isolate FIN_2018_H_25 was from a serum
sample of a 48-year-old female who lived in Tampere, and
FIN_2018_H_05 was from a 36-year-old female from Kuo-
pio. These two female patients did not have serological di-
agnosis, as only a single sample with no antibodies detected
was received by the laboratory. Before this study, the isolates
from patients in Finland originated from whole blood (n = 1)
and skin lesions (n = 3) from Ilomantsi and Kiihtelysvaara
(Kurkela et al. 2004).
Discussion
In this study we detected SINV RNA initially in serum
samples of eight patients but when repeated, one of the
samples remained negative. This sample had shown posi-
tivity only at late cycles in the initial screening. Two of the
SINV RNA positive patients were from the group of patients
with serological diagnosis based on paired samples, and the
RNA positivity was confirmed by virus isolation in one of
them. We detected SINV RNA repeatedly also in additional
five patients, who had no serodiagnosis and isolated the virus
in two of them. This was surprising as, before this work,
SINV has been rarely isolated from human sera, and the
SINV RNA detection has been considered not suitable for
diagnostic use (Sane et al. 2012a). These undiagnosed SINV
RNA positive patients were suspected for SINV infection, but
were left undiagnosed likely due to the early sampling time
point and the lack of a consequent sample. These results
encourage further studies on SINV patient serum samples and
their wider research use in SINV RNA and virus detection.
The sequence analysis of the three virus isolates obtained
in this study from patients originating from different geo-
graphical locations during the epidemic season of 2018
suggested the strains to be divergent from another raising the
question of possible strain characteristics in relation to
pathogenic properties, viremia levels, and its duration. Un-
fortunately, for the patients lacking the serodiagnosis no
clinical data were available, including the timing of disease
onset in regard to sampling time point.
In Finland, the mosquito isolate obtained in this study, and
in the previous work involving the same area (Sane et al.
2012b), are all most likely originating from Ochlerotatus



































































































































































species. Yet, in the previous study by Sane et al. (2012b) this
was not confirmed through morphological species identifi-
cation of mosquitoes tested positive for SINV. The ornitho-
philic Culex and Culiseta mosquitoes are globally considered
the main vector genera for SINV, with virus detection and
isolation in several countries, including Kenya, Saudi Arabia,
Israel, Germany, and Sweden (Lundstrom et al. 1990, Hesson
et al. 2015, Ling et al. 2019). However, SINV has also been
detected from other mosquito genera, such as Aedes (Lvov
et al. 1984, Ling et al. 2019) and Ochlerotatus (Tingstrom
et al. 2016), but their relevance for SINV circulation in nature
or role in transmission to humans is not well characterized.
In this study, the morphological characteristics identified
the virus positive mosquitoes as members of Ochlerotatus
genus, but the reliable molecular identification of the species
was restricted due to the sample pooling and the lack of high
identity sequences in the databases. Unfortunately, the mor-
phological identification to species level was not definitive as
the voucher specimens had lost some of the features neces-
sary for species level identification, and there are several
species of Ochlerotatus mosquitoes in Finland. Interestingly,
Ochlerotatus spp. have been reported to be frequent man
biters in Finland in contrast to Culex spp considered to be
more ornithophilic (Utrio 1979). Thus Ochlerotatus spp.
could be involved in transmission of SINV to humans. Fur-
ther work on morphological and genetic characterization of
the local vector species in Finland would be needed to un-
ravel the possible vector effects to the special epidemiolog-
ical characteristics of SINV in Finland.
Interestingly, strains clustering phylogenetically represent
regions with different epidemiological characteristics. Be-
sides Finland, the epidemic SINV with human disease is
known to occur in Russia (Laine et al. 2004) and Sweden
(Lundstrom et al. 1991, Ahlm et al. 2014) and very rarely in
Germany ( Jost et al. 2011). In Finland SINV patients are
diagnosed yearly with occasional outbreaks. The known
risk factors for contracting SINV infection in Finland in-
clude exposure to mosquito bites during outdoor activities
and living in rural areas ( Jalava et al. 2013). In contrast in
Germany, where no human outbreaks have been docu-
mented, SINV has been detected from urban environments,
including ornithophilic Culex spp. mosquitoes and urban
bird species ( Jost et al. 2010, Eiden et al. 2014, Scheuch
et al. 2018). In Finland SINV has been associated with
migratory and resident birds and especially with grouse that
inhabit rural forests. The resident grouse and passerines
have been shown to have antibodies against SINV, and the
fluctuation of the grouse population density has been found
to correlate with human epidemics in Finland (Kurkela et al.
2008, Jalava et al. 2013). Whether the changing climate
or different SINV strains would enable urban SINV circu-
lation also outside Germany, and in Finland, remains to be
studied.
Conclusion
We conclude that SINV in Finland is genetically more
divergent in Finland than previously known, and the results
from patient sera demonstrate its potential in SINV detection
and strain characterization for research use. The phylogenetic
analysis of the new strains provides evidence of SINV strain
transfer and circulation within Europe. SINV strains from
Finland grouped closely with strains from Sweden and Ger-
many that in contrast to Finland represent areas with rare or
nonexisting SINV disease. The possible effects of local
vector species selection involved in SINV transmission and
the role of Ochlerotatus mosquitoes as possible bridge vec-
tors of SINV to humans in Finland and elsewhere in Northern
Europe remains to be studied.
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